Open AccessIncreased Anandamide and Decreased Pain and Depression after Exercise in Fibromyalgia
Author(s) -
Niclas Stensson,
Björn Gerdle,
Malin Ernberg,
Kaisa Mannerkorpi,
Eva Kosek,
Bijar Ghafouri
Publication year - 2020
Publication title -
medicine and science in sports and exercise
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.703
H-Index - 224
eISSN - 1530-0315
pISSN - 0195-9131
DOI - 10.1249/mss.0000000000002293
Subject(s) - anandamide , fibromyalgia , medicine , depression (economics) , physical therapy , endocannabinoid system , context (archaeology) , chronic pain , palmitoylethanolamide , physical medicine and rehabilitation , cannabinoid receptor , biology , paleontology , receptor , economics , macroeconomics , agonist
Physical exercise is increasingly being promoted by health care for chronic pain conditions with beneficial outcomes, such as pain and fatigue reduction, and increased quality of life. Nevertheless, knowledge about biochemical consequences of physical exercise in chronic pain is still relatively poor. The endocannabinoid system has been suggested to play a role for acute exercise-induced reward and pain inhibition. The aim of this study is to investigate the chronic outcomes of resistance exercise on levels of endocannabinoids and related lipids in fibromyalgia (FM).